Kimia Farma
Kimia Farma, officially known as PT Kimia Farma Tbk, is a prominent player in Indonesia's pharmaceutical industry, headquartered in Jakarta. Established in 1817, it stands as one of the oldest pharmaceutical companies in the country, with a rich history marked by significant milestones in healthcare innovation and accessibility. The company operates extensively across Indonesia, focusing on the production and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and herbal remedies. Kimia Farma is renowned for its commitment to quality and affordability, making healthcare accessible to a broader population. With a strong market position, Kimia Farma has achieved notable recognition for its extensive network of pharmacies and healthcare services, contributing significantly to Indonesia's healthcare landscape. Its dedication to research and development further solidifies its reputation as a leader in the pharmaceutical sector.
DitchCarbon Score
How does Kimia Farma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kimia Farma's score of 0 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kimia Farma's reported carbon emissions
In 2022, Kimia Farma reported total carbon emissions of approximately 509,246,840 kg CO2e, primarily from Scope 1 emissions. This marked a significant reduction from 2021, where emissions were about 1,085,841,150 kg CO2e. The company has shown a downward trend in emissions over the years, with 2020 emissions at approximately 193,144,650 kg CO2e for Scope 1 and 406,753,010 kg CO2e for Scope 3. Despite these reductions, Kimia Farma has not established specific reduction targets or commitments under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of formal reduction initiatives suggests that while the company is making progress in reducing its carbon footprint, there is potential for more structured climate commitments to enhance its sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Scope 1 | 806,998,930 | 000,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 |
| Scope 2 | 806,998,930 | 000,000,000 | - | - | - |
| Scope 3 | 806,998,930 | 000,000,000 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kimia Farma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
